Differences in complications, cardiovascular risk factor, and diabetes management among participants enrolled at veterans affairs (VA) and non-VA medical centers in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE)-Reference-Cited by-同舟云学术

Differences in complications, cardiovascular risk factor, and diabetes management among participants enrolled at veterans affairs (VA) and non-VA medical centers in the glycemia reduction approaches in diabetes: A comparative effectiveness study (GRADE)

Published:2022-02 Issue: Volume:184 Page:109188
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Florez Hermes J.,Ghosh Alokananda,Pop-Busui Rodica,Hox Sophia H.,Underkofler Chantal,McKee M. Diane,Park Jean,Rhee Mary K.,Killean Tina,Krause-Steinrauf Heidi,Aroda Vanita R.,Wexler Deborah J.

Funder

AstraZeneca

National Institutes of Health

National Institute of Diabetes and Digestive and Kidney Diseases

Publisher

Elsevier BV

Subject

Endocrinology,General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference27 articles.

1. Centers for Disease Control. Type 2 Diabetes. https://www.cdc.gov/diabetes/basics/type2.html, accessed May 13, 2021.

2. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis;Udler;PLoS Med,2018

3. Association of baseline characteristics with insulin sensitivity and beta-cell function in the glycemia reduction approaches in diabetes: a comparative effectiveness (GRADE) study cohort;Rasouli;Diabetes Care,2021